Anxiety as a predictor and outcome variable in the Multimodal Treatment Study of Children with ADHD (MTA)

被引:160
|
作者
March, JS [1 ]
Swanson, JM [1 ]
Arnold, LE [1 ]
Hoza, B [1 ]
Conners, CK [1 ]
Hinshaw, SP [1 ]
Hechtman, L [1 ]
Kraemer, HC [1 ]
Greenhill, LL [1 ]
Abikoff, HB [1 ]
Elliott, LG [1 ]
Jensen, PS [1 ]
Newcorn, JH [1 ]
Vitiello, B [1 ]
Severe, J [1 ]
Wells, KC [1 ]
Pelham, WE [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Psychol, Durham, NC 27710 USA
关键词
ADHD; attention deficit; anxiety; comorbidity; treatment; outcomes; classification; diagnosis;
D O I
10.1023/A:1005179014321
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Initial moderator analyses in the Multimodal Treatment Study of Children with ADHD (MTA) suggested that child anxiety ascertained by parent report on the Diagnostic Interview Schedule for Children 2.3 (DISC Anxiety) differentially moderated the outcome of treatment. Left unanswered were questions regarding the nature of DISC Anxiety, the impact of comorbid conduct problems on the moderating effect of DISC Anxiety, and the clinical significance of DISC Anxiety as a moderator of treatment outcome. Thirty-three percent of MTA subjects met DSM-III-R criteria for an anxiety disorder excluding simple phobias. Of these, two-thirds also met DSM-III-R criteria for comorbid oppositional-defiant or conduct disorder whereas one-third did not, yielding an odds ratio of approximately two for DISC Anxiety, given conduct problems. In this context, exploratory analyses of baseline data suggest that DISC Anxiety may reflect parental attributions regarding child negative affectivity and associated behavior problems (unlike fearfulness), particularly in the area of social interactions, another core component of anxiety that is more typically associated with phobic symptoms. Analyses using hierarchical linear modeling (HLM) indicate that the moderating effect of DISC Anxiety continues to favor the inclusion of psychosocial treatment for anxious ADHD children irrespective of the presence or absence of comorbid conduct problems. This effect, which is clinically meaningful, is confined primarily to parent-reported outcomes involving disruptive behavior, internalizing symptoms, and inattention: and is generally stronger for combined than unimodal treatment. Contravening earlier studies, no adverse effect of anxiety on medication response for core ADHD or other outcomes in anxious or nonanxious ADHD children was demonstrated. When treating ADHD, it is important to search for comorbid anxiety and negative affectivity and to adjust treatment strategies accordingly.
引用
收藏
页码:527 / 541
页数:15
相关论文
共 50 条
  • [31] A clinical review of outcomes of the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (MTA)
    Murray D.W.
    Arnold L.E.
    Swanson J.
    Wells K.
    Burns K.
    Jensen P.
    Hechtman L.
    Paykina N.
    Legato L.
    Strauss T.
    Current Psychiatry Reports, 2008, 10 (5) : 424 - 431
  • [32] Gestational and postnatal tobacco smoke exposure as predictor of ADHD, comorbid ODD/CD, and treatment response in the MTA
    Arnold, LE
    Elliott, M
    Lindsay, RL
    Molina, B
    Cornelius, MD
    Vitiello, B
    Hechtman, L
    Elliott, GR
    Newcorn, J
    Epstein, JN
    Wigal, T
    Swanson, JM
    Wells, K
    CLINICAL NEUROSCIENCE RESEARCH, 2005, 5 (5-6) : 295 - 306
  • [33] Comorbidity prevalence and treatment outcome in children and adolescents with ADHD
    Reale, Laura
    Bartoli, Beatrice
    Cartabia, Massimo
    Zanetti, Michele
    Costantino, Maria Antonella
    Canevini, Maria Paola
    Termine, Cristiano
    Bonati, Maurizio
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2017, 26 (12) : 1443 - 1457
  • [34] Comorbidity prevalence and treatment outcome in children and adolescents with ADHD
    Laura Reale
    Beatrice Bartoli
    Massimo Cartabia
    Michele Zanetti
    Maria Antonella Costantino
    Maria Paola Canevini
    Cristiano Termine
    Maurizio Bonati
    European Child & Adolescent Psychiatry, 2017, 26 : 1443 - 1457
  • [35] Memory modification as an outcome variable in anxiety disorder treatment
    Tryon, Warren W.
    McKay, Dean
    JOURNAL OF ANXIETY DISORDERS, 2009, 23 (04) : 546 - 556
  • [36] Blood Pressure and Heart Rate Over 10 Years in the Multimodal Treatment Study of Children With ADHD
    Vitiello, Benedetto
    Elliott, Glen R.
    Swanson, James M.
    Arnold, L. Eugene
    Hechtman, Lily
    Abikoff, Howard
    Molina, Brooke S. G.
    Wells, Karen
    Wigal, Timothy
    Jensen, Peter S.
    Greenhill, Laurence L.
    Kaltman, Jonathan R.
    Severe, Joanne B.
    Odbert, Carol
    Hur, Kwan
    Gibbons, Robert
    AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (02): : 167 - 177
  • [37] NIMH COLLABORATIVE MULTISITE MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ADHD .1. BACKGROUND AND RATIONALE
    RICHTERS, JE
    ARNOLD, LE
    JENSEN, PS
    ABIKOFF, H
    CONNERS, CK
    GREENHILL, LL
    HECHTMAN, L
    HINSHAW, SP
    PELHAM, WE
    SWANSON, JM
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1995, 34 (08): : 987 - 1000
  • [38] Comorbid ADHD: Implications for the Treatment of Anxiety Disorders in Children and Adolescents
    Halldorsdottir, Thorhildur
    Ollendick, Thomas H.
    COGNITIVE AND BEHAVIORAL PRACTICE, 2014, 21 (03) : 310 - 322
  • [39] Neurotherapy as a treatment of children with ADHD and anxiety, as co-morbidity
    Rubí, MCM
    Hernández, LG
    Benítez, AG
    APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 2005, 30 (04) : 411 - 411
  • [40] A MULTIMODAL EXAMINATION OF IMPULSIVITY AS A PREDICTOR OF OUTCOME FROM TREATMENT FOR BULIMIA NERVOSA
    Manasse, Stephanie
    Hunt, Rowan
    Juarascio, Adrienne
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S267 - S267